Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
16522
Kawatani M, Aono H, Hiranuma S, Shimizu T, Muroi M, Ogawa N, Ohishi T, Ohba SI, Kawada M, Nogawa T, Okano A, Hashizume D, Osada H.
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell GrowthACS Chem Biol
2021
16(8):1576-1586
PubMed ID: 34296611
DOI: 10.1021/acschembio.1c00480
9713
Sakamoto R, Kakinuma E, Masuda K, Takeuchi Y, Ito K, Iketaki K, Matsuzaki T, Nakabayashi S, Yoshikawa HY, Yamamoto H, Sato Y, Tanii T.
Quantitative comparison of cancer and normal cell adhesion using organosilane monolayer templates: an experimental study on the anti-adhesion effect of green-tea catechins.In Vitro Cell. Dev. Biol. Anim.
2016
52:799-805
PubMed ID: 27251159
DOI: 10.1007/s11626-016-0049-6
7928
Shoji Y, Miyamoto M, Ishikawa K, Yoshioka T, Mishra R, Ichinokawa K, Matsumura Y, Itoh T, Shinohara T, Hirano S, Kondo S.
The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.J Surg Oncol
2011
103:230-8
PubMed ID: 21337550
DOI: 10.1002/jso.21812
5875
Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.
Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.Int J Oncol
2009
34(5):1231-40
PubMed ID: 19360336